Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ANGIODYNAMICS, INC.

(ANGO)
  Report
Delayed Nasdaq  -  04:00:00 2023-05-26 pm EDT
9.290 USD   -0.85%
04/18North American Morning Briefing: China Data Helps -3-
DJ
04/17Raymond James Downgrades AngioDynamics to Outperform From Strong Buy, Trims Price Target to $13 From $14
MT
04/17Angiodynamics Inc : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ANGIODYNAMICS, INC.
04/17Raymond James Downgrades AngioDynamics to Outperform From Strong Buy, Trims Price Targe..
MT
04/11AngioDynamics to Present at the Needham Virtual Healthcare Conference
BU
04/03Raymond James Adjusts Price Target on AngioDynamics to $14 From $22, Maintains Strong B..
MT
03/31AngioDynamics Develops Exciting New Partnerships with Addlife in the UK, Ireland, and N..
AQ
03/30Sector Update: Health Care Stocks Higher Premarket Thursday
MT
03/30Sector Update: Health Care
MT
03/30AngioDynamics Swings to Fiscal Q3 Loss, Net Sales Rise; Lowers FY2023 Guidance; Shares ..
MT
03/30Transcript : AngioDynamics, Inc., Q3 2023 Earnings Call, Mar 30, 2023
CI
03/30AngioDynamics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ende..
CI
03/30Earnings Flash (ANGO) ANGIODYNAMICS Posts Q3 Revenue $80.7M, vs. Street Est of $83.2M
MT
03/30Angiodynamics : Fiscal Q3 Earnings Snapshot
AQ
03/30AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance
BU
03/30Angiodynamics, Inc. Revised Revenue Guidance for the Fiscal 2023
CI
03/13AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023
BU
02/28AngioDynamics to Participate in Three Investor Conferences in March
BU
More most relevant news
All news about ANGIODYNAMICS, INC.
04/18North American Morning Briefing: China Data Helps -3-
DJ
04/17Raymond James Downgrades AngioDynamics to Outperform From Strong Buy, Trims Price Targe..
MT
04/17Angiodynamics Inc : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
04/11AngioDynamics to Present at the Needham Virtual Healthcare Conference
BU
04/03Raymond James Adjusts Price Target on AngioDynamics to $14 From $22, Maintains Strong B..
MT
03/31ANGIODYNAMICS INC Management's Discussion and Analysis of Financial Condition and Resu..
AQ
03/31AngioDynamics Develops Exciting New Partnerships with Addlife in the UK, Ireland, and N..
AQ
03/30Top Midday Decliners
MT
03/30Sector Update: Health Care Stocks Higher Premarket Thursday
MT
03/30Sector Update: Health Care
MT
More news
News in other languages on ANGIODYNAMICS, INC.
03/30Principales baisses en milieu de journée
03/30Mise à jour sectorielle : Les actions du secteur de la santé son..
03/30Mise à jour sectorielle : Soins de santé
03/30Les contrats à terme sur actions américaines sont en hausse avant les rapports sur le P..
03/30AngioDynamics subit une perte au troisième trimestre fiscal, le chiffre d'affaires net ..
03/30AngioDynamics, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois ..
03/30Angiodynamics, Inc. Révision des prévisions de chiffre d'affaires pour l'exercice 2023
02/27AngioDynamics, Inc. annonce des changements au conseil d'administration
01/05Mise à jour sectorielle : Les actions du secteur de la santé son..
01/05AngioDynamics, affiche un bénéfice ajusté et une hausse des ventes au deuxième trimestr..
More news
Analyst Recommendations on ANGIODYNAMICS, INC.
04/17Raymond James Downgrades AngioDynamics to Outperform From Strong Buy, Trims Price Targe..
MT
04/03Raymond James Adjusts Price Target on AngioDynamics to $14 From $22, Maintains Strong B..
MT
01/06Raymond James Adjusts AngioDynamics' Price Target to $22 From $25, Keeps Strong Buy Rat..
MT
2022Raymond James Adjusts AngioDynamics' Price Target to $25 from $27, Maintains Strong Buy..
MT
2022Raymond James Adjusts AngioDynamics' Price Target to $27 from $32, Keeps Strong Buy Rat..
MT
More recommendations
Press releases
04/17Angiodynamics Inc : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
04/11AngioDynamics to Present at the Needham Virtual Healthcare Conference
BU
03/31ANGIODYNAMICS INC Management's Discussion and Analysis of Financial Condition and Resu..
AQ
03/31AngioDynamics Develops Exciting New Partnerships with Addlife in the UK, Ireland, and N..
AQ
03/30Angiodynamics Inc : Results of Operations and Financial Condition, Regulation FD Disclosur..
AQ
More press releases
Upcoming event on ANGIODYNAMICS, INC.
-40% off: Our subscriptions help you unlock hidden opportunities!
Subscribe
fermer